Your browser doesn't support javascript.
loading
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
Alig, S K; Esfahani, M Shahrokh; Garofalo, A; Li, M Y; Rossi, C; Adams, R; Binkley, M S; Jin, M C; Olsen, M; Telenius, A; Mutter, J; Sworder, B J; Schroers-Martin, J; King, D A; Schultz, A; Bögeholz, J; Su, S; Kathuria, K R; Kang, X; Liu, C L; Spina, V; Tousseyn, T; Buedts, L; Flerlage, T; Flerlage, J E; Castellino, S M; Advani, R; Rossi, D; Lynch, R; Ghesquières, H; Casasnovas, O; Kurtz, D M; Marks, L J; Link, M P; André, M; Vandenberghe, P; Steidl, C; Diehn, M; Alizadeh, A A.
Afiliación
  • Alig SK; Stanford University, Department of Medicine, Division of Oncology, Stanford, California, USA.
  • Esfahani MS; Stanford University, Department of Medicine, Division of Oncology, Stanford, California, USA.
  • Garofalo A; Stanford University, Department of Medicine, Division of Oncology, Stanford, California, USA.
  • Li MY; British Columbia Cancer, Centre for Lymphoid Cancer, Vancouver, Canada.
  • Rossi C; Stanford University, Department of Medicine, Division of Oncology, Stanford, California, USA.
  • Adams R; Stanford University, Department of Pediatrics, Division of Pediatric Hematology and Oncology, Stanford, California, USA.
  • Binkley MS; Stanford University, Department of Radiation Oncology, Stanford, California, USA.
  • Jin MC; Stanford University, Department of Medicine, Division of Oncology, Stanford, California, USA.
  • Olsen M; Stanford University, Department of Medicine, Division of Oncology, Stanford, California, USA.
  • Telenius A; British Columbia Cancer, Centre for Lymphoid Cancer, Vancouver, Canada.
  • Mutter J; Stanford University, Department of Medicine, Division of Oncology, Stanford, California, USA.
  • Sworder BJ; Stanford University, Department of Medicine, Division of Oncology, Stanford, California, USA.
  • Schroers-Martin J; Stanford University, Department of Medicine, Division of Oncology, Stanford, California, USA.
  • King DA; Stanford University, Department of Medicine, Division of Oncology, Stanford, California, USA.
  • Schultz A; Stanford University, Department of Medicine, Division of Oncology, Stanford, California, USA.
  • Bögeholz J; Stanford University, Department of Medicine, Division of Oncology, Stanford, California, USA.
  • Su S; Stanford University, Department of Radiation Oncology, Stanford, California, USA.
  • Kathuria KR; Stanford University, Department of Medicine, Division of Oncology, Stanford, California, USA.
  • Kang X; Stanford University, Department of Medicine, Division of Oncology, Stanford, California, USA.
  • Liu CL; Stanford University, Department of Medicine, Division of Oncology, Stanford, California, USA.
  • Spina V; Oncology Institute of Southern Switzerland and Institute of Oncology Research, Bellinzona, Switzerland.
  • Tousseyn T; KU Leuven, Department of Imaging & Pathology, Leuven, Belgium.
  • Buedts L; KU Leuven, Department of Human Genetics, Leuven, Belgium.
  • Flerlage T; St. Jude Children's Research Hospital, Department of Infectious Diseases, Memphis, Tennessee, USA.
  • Flerlage JE; St. Jude Children's Research Hospital, Department of Oncology, Memphis, Tennessee, USA.
  • Castellino SM; Emory University, Department of Pediatrics, Atlanta, Georgia, USA.
  • Advani R; Stanford University, Department of Medicine, Division of Oncology, Stanford, California, USA.
  • Rossi D; Oncology Institute of Southern Switzerland and Institute of Oncology Research, Bellinzona, Switzerland.
  • Lynch R; Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, Washington, USA.
  • Ghesquières H; Centre Hospitalier Lyon Sud, Department of Hematology, Pierre-Bénite, France.
  • Casasnovas O; University Hospital F. Mitterrand and Inserm UMR 1231, Hematology Department, Dijon, France.
  • Kurtz DM; Stanford University, Department of Medicine, Division of Oncology, Stanford, California, USA.
  • Marks LJ; Stanford University, Department of Pediatrics, Division of Pediatric Hematology and Oncology, Stanford, California, USA.
  • Link MP; Stanford University, Department of Pediatrics, Division of Pediatric Hematology and Oncology, Stanford, California, USA.
  • André M; Université Catholique de Louvain, CHU UCL Namur, Department of Hematology, Yvoir, France.
  • Vandenberghe P; KU Leuven, Department of Human Genetics, Leuven, Belgium.
  • Steidl C; British Columbia Cancer, Centre for Lymphoid Cancer, Vancouver, Canada.
  • Diehn M; Stanford University, Department of Radiation Oncology, Stanford, California, USA.
  • Alizadeh AA; Stanford University, Department of Medicine, Division of Oncology, Stanford, California, USA.
Hematol Oncol ; 41 Suppl 2: 96-98, 2023 Jun.
Article en En | MEDLINE | ID: mdl-39112400
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Hematol Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Hematol Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos